<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neuronal cell damage following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> is postulated to be due to free radical induced <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, and <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> is supposedly an important non-enzymatic scavenger of such free radicals </plain></SENT>
<SENT sid="1" pm="."><plain>This study was undertaken to evaluate the protective effect of <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> on the brain in a primate model after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Consumption of <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> in the monkey brain following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> and its effect on macroscopic <z:mpath ids='MPATH_124'>infarct</z:mpath> size as demonstrated by 2, 3, 5, Triphenyl tetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> (TTC) staining were used as parameters </plain></SENT>
<SENT sid="3" pm="."><plain>The monkeys in the treated group were given 1 gram <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> parenterally every day for six days </plain></SENT>
<SENT sid="4" pm="."><plain>The mean level of total <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> in right basal ganglia was 35.1 +/- 4.2 micrograms/mg of protein in the treated group as opposed to 22.9 +/- 2.1 micrograms/mg of protein in the nontreated group both before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>After right middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> to produce focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>, the total <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> in the right basal ganglia 2 hours post <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> was 13.3 +/- 3.1 micrograms/mg of protein in the treated group as opposed to 9 +/- 1.6 micrograms/mg of protein in the untreated group </plain></SENT>
<SENT sid="6" pm="."><plain>The average consumption of total <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> was 21.8 micrograms/mg of protein in the treated group and 13.9 micrograms/mg of protein in the nontreated group </plain></SENT>
<SENT sid="7" pm="."><plain>Macroscopic <z:mpath ids='MPATH_124'>infarct</z:mpath> size as determined by TTC staining in the right cerebral hemisphere was 11.7 +/- 6.9 in treated group whereas it was 24.4 +/- 4.4 (expressed as percentage of right hemisphere) in the non-treated group </plain></SENT>
<SENT sid="8" pm="."><plain>There was significant reduction in the size of the <z:mpath ids='MPATH_124'>infarct</z:mpath> in the treated group.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>